First Patient in Texas, Southeast US, Enrolled at UTHealth Houston for Study of Neural Cell Therapy Product to Treat Epilepsy
University of Texas Health Science Center at HoustonUTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.